Metsera
Biotechnology company developing next-generation obesity and metabolic disease therapies, including novel GLP-1 agonists and other innovative approaches to weight management.
Website
https://www.metsera.comLocation
New York, New York, USA
Founded
2022
Investors
3
Categories
therapeutics, biotech, pharma, obesity, metabolic-disease, cardiovascular, glp-1
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| ARCH Venture Partners | Chicago, USA | biotech-focused | seedseries-a+3 | 6 |
| SoftBank Vision Fund | Tokyo, Japan & London, UK | generalist | series-bseries-c+1 | 2 |
| Mubadala Capital | Abu Dhabi, UAE | pe | series-bseries-c+1 | 1 |